Yale Cancer Center researchers were awarded an $11 million grant renewal from the NCI to fund the Yale Specialized Program of Research Excellence in lung cancer.
Renee Read, a researcher in the Cell and Molecular Biology Research Program at Winship Cancer Institute of Emory University, has received the Ben and Catherine Ivy Foundation Emerging Leader Grant Award, which provides $500,000 for a 24-month project beginning July 1.
The National Institute for Health and Care Excellence and Flatiron Health are exploring how real-world evidence can inform the clinical and cost effectiveness of health technologies.
MD Anderson Cancer Center and Sanofi announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.
The Hackensack Meridian Center for Discovery and Innovation and Merck are investigating drugs for treatment of COVID-19.
Seth D. Cohen was appointed to the newly created position of regional director of Oncology Services for the RWJBarnabas Health Southern Region.
Leading cancer fighting organizations from across the United States submitted a letter to President Donald Trump and his administration, urging that the decision to withdraw from the World Health Organization be reconsidered.
The FDA Oncologic Drugs Advisory Committee July 14 voted 12-0 to recommend approval for belantamab mafodotin for relapsed or refractory multiple myeloma.
Summer of 2020 was supposed to be a brief period of respite between Wave 1 and Wave 2 of COVID-19, but out of sheer stubbornness, for reasons political, or both, SARS-CoV-2 didn't get the message.
Inqovi (decitabine and cedazuridine) has received approval for at-home treatment of adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
